This proposal describes experiments that will characterize elements
which regulate the astrocyte-specific expression of the glial fibrillary
acidic protein (GFAP) gene. This gene encodes the major component of
astrocyte intermediate filaments and is spatially and temporally
regulated in the developing central nervous system. Astrocytes
constitute nearly 40% of the CNS cell population and are responsible for
structural, nutritional, developmental and biochemical support of the
neurons. They also play an important role in CNS response to disease and
injury and give rise to a significant portion of CNS tumors in adults.
Understanding the mechanisms which regulate astrocyte growth and
differentiation is important for future studies of CNS development and
glial cell transformation. Transcriptional regulation of the GFAP gene
can serve as a system for the identification of molecular signals which
modulate glial cell differentiation: the gene is expressed upon
differentiation of immature glial cells to mature astrocyte suggesting
that factors regulating its transcription play a major role in astroglial
differentiation. A 5'-flanking region of the gene was cloned land is
able to direct glial-specific reporter gene expression in transfected
cells. Transfection of deletion constructs revealed that a cell-specific
regulatory region resides upstream of the gene promoter. Primer
extension analysis verified transcriptional regulation of constructs in
transfected cells. An upstream cis-acting element has been identified.
Gel shift assays have identified glial-specific trans-acting factor which
bind to the cis-acting element. DNA sequence analysis, coupled with
DNase assays, will , locate and identify more precisely the sequence
motifs which bind to cell-specific trans-acting factors. cDNA libraries
was prepared from mRNA of transformed glial cells, and a similar library
will be made from primary astrocytes. Sequence motifs which bind to
cell-specific nuclear factors will be used for screening the cDNA
expression libraries and isolating cDNA clones which encode DNA-binding
proteins. These clones will be used for studies of their role in the
process of astrocyte differentiation
and oncogenic transformation.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
030811269
UEI
QN6MS4VN7BD1
Project Start Date
01-May-1991
Project End Date
30-April-1995
Budget Start Date
01-May-1991
Budget End Date
30-April-1992
Project Funding Information for 1991
Total Funding
$182,769
Direct Costs
$110,256
Indirect Costs
$72,513
Year
Funding IC
FY Total Cost by IC
1991
National Institute of Neurological Disorders and Stroke
$182,769
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS028662-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS028662-01A1
Patents
No Patents information available for 1R01NS028662-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS028662-01A1
Clinical Studies
No Clinical Studies information available for 1R01NS028662-01A1
News and More
Related News Releases
No news release information available for 1R01NS028662-01A1
History
No Historical information available for 1R01NS028662-01A1
Similar Projects
No Similar Projects information available for 1R01NS028662-01A1